The Pharmaceutics Editorial Office retracts the article, “A Novel Drug Self-Delivery System from Fatty Alcohol Esters of Tranexamic Acid for Venous Malformation Sclerotherapy” [1], cited above.
Following publication, the authors raised concerns to the publisher regarding a number of scientific and images errors.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and Editorial Board, that confirmed the overlap of subsections of Figure 7B (NS group, 1 d and 15 d), incorrect association of subfigures 8B and 8C to the named experimental animals, and writing errors in the Material and Method section.
As a result, the Editorial Office and Editorial Board were unable to confirm the reliability of the findings and subsequently decided to retract this paper as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Pharmaceutics.
The authors agreed to this retraction.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Chen Y., Song D., Hou Q., Ma M., Zhao X., Yang T., Xie H., Ding P. RETRACTED: A Novel Drug Self-Delivery System from Fatty Alcohol Esters of Tranexamic Acid for Venous Malformation Sclerotherapy. Pharmaceutics. 2022;14:343. doi: 10.3390/pharmaceutics14020343. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]